Genomictree KRX:228760KOSDAQ
지노믹트리 · Korean news coverage and regulatory filings, organized.
Articles, 24h3
Articles, 7 days3
DART filings, 7 days0
Articles tracked3since Sep 11
In Q2 2026, Genomictree reported revenue of ₩842m, down 51.1% year on year, and an operating loss of ₩2.6bn. Genomictree (지노믹트리) appeared in 3 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Sep 15 with 3 articles.
Filing signals 4 quarters of losses Screener
Genomictree quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩842m | -51.1% | −₩2.6bn | −₩2.5bn |
| Q1 2026 | ₩382m | +20.6% | −₩3.0bn | −₩2.0bn |
| Q4 2025 derived | ₩826m | +0.1% | −₩2.6bn | −₩2.0bn |
| Q3 2025 | ₩897m | +29.3% | −₩3.4bn | −₩2.8bn |
| Q2 2025 | ₩1.7bn | +207.5% | −₩1.5bn | −₩1.5bn |
| Q1 2025 | ₩316m | +11.2% | −₩3.7bn | −₩3.0bn |
| Q4 2024 derived | ₩824m | +24.6% | −₩3.7bn | −₩1.8bn |
| Q3 2024 | ₩693m | +30.3% | −₩3.9bn | −₩3.1bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.
Genomictree top stories 2 weeks, by number of outlets
- 1
Latest Genomictree news Korean headlines
-
지노믹트리, 중추신경계 mRNA 전달 LNP 기술 개발
2 more on this story · 1 outlets
- 지노믹트리, 뇌·척수에 mRNA 전달하는 LNP 기술 개발이데일리 · 10:24
- 지노믹트리, 뇌·척수에 mRNA 전달하는 LNP 기술 개발이데일리 · 10:25